Patient Experiences Following Urinary Diversion as Part of Surgery for Advanced and Recurrent Rectal Cancer
Not Applicable
- Conditions
- Health Condition 1: C20- Malignant neoplasm of rectum
- Registration Number
- CTRI/2022/01/039441
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Histologically proven advanced rectal cancer
-Must have urinary diversion / reconstruction
-Able and willing to give written informed consent
-Able to assess email/internet
Exclusion Criteria
-Strong evidence of metastatic or peritoneal disease
-Palliative exenteration
-Colonic obstruction
-Pelvic exenteration for non-rectal neoplasm
-Inability to answer online questionnaires
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the 30-day complication rate of urinary diversion/reconstruction following pelvic exenteration <br/ ><br> <br/ ><br>-To assess the impact of urinary diversion/reconstruction subtypes on quality of life at: <br/ ><br>Day-30,Month 3, Month 6 ,year 1 <br/ ><br> <br/ ><br>Timepoint: <br/ ><br> <br/ ><br>12 months
- Secondary Outcome Measures
Name Time Method -To assess the short/medium-term complications associated with the subtypes of urinary diversion/reconstruction at 6-months and 1- <br/ ><br>-To assess the rate of intervention to modify or intervene due to urinary diversion/reconstruction complicationsTimepoint: 12 month